FDA Approved: CORDRAN — Supplemental Application (INA Pharmaceutics, Inc)

View source ↗

Summary

FDA approved a supplemental application for Cordran (Flurandrenolide) submitted by INA Pharmaceutics, Inc. The update pertains to changes to the product's label…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Dermatitis
• Diaper Dermatitis

Drugs mentioned

• CORDRAN (FLURANDRENOLIDE)

Snippet

SUPPL AP for CORDRAN (FLURANDRENOLIDE)